VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $8,132,000 | -52.4% | 80,000 | -16.5% | 0.29% | -57.4% |
| Q3 2015 | $17,101,000 | -55.0% | 95,865 | -44.0% | 0.67% | -46.4% |
| Q2 2015 | $38,023,000 | +31.1% | 171,160 | +17.2% | 1.25% | +25.2% |
| Q1 2015 | $29,005,000 | +18.3% | 146,029 | -14.8% | 1.00% | +6.2% |
| Q4 2014 | $24,518,000 | -24.7% | 171,331 | -30.9% | 0.94% | -2.3% |
| Q3 2014 | $32,552,000 | +47.0% | 248,110 | +41.3% | 0.96% | +30.5% |
| Q2 2014 | $22,150,000 | +12.0% | 175,623 | +17.1% | 0.74% | +43.6% |
| Q1 2014 | $19,775,000 | -52.8% | 150,000 | -57.9% | 0.51% | -59.7% |
| Q4 2013 | $41,875,000 | +418.3% | 356,687 | +360.6% | 1.28% | +323.6% |
| Q3 2013 | $8,079,000 | +6.0% | 77,433 | -12.5% | 0.30% | -7.1% |
| Q2 2013 | $7,619,000 | – | 88,505 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |